Form 4: Northrop Grumman Director Sells Shares Under 10b5-1 Plan

Northrop Grumman director Mark A. Welsh III sold a total of 33 shares of common stock on January 6, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Mark A. Welsh III, a director at Northrop Grumman, sold a total of 33 shares of common stock on January 6, 2025.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan.
• The transactions occurred at various prices, ranging from $454.26 to $463.99 per share.
• The sales resulted in a decrease in Mr. Welsh's direct holdings of Northrop Grumman stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to insider trading. It does not contain any information that would significantly impact the sentiment of the stock.

Risks

• Sales by insiders can sometimes be perceived negatively by the market, potentially impacting the stock price.

Industry Context

This is a routine filing related to insider trading activity and is common for publicly traded companies. It does not indicate any specific trend in the aerospace and defense industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for all publicly traded companies in the US.
• The sales are not unusual and are within the normal range of insider trading activity.
• Many directors and officers of public companies use 10b5-1 plans to manage their personal finances and avoid accusations of insider trading.

Stakeholder Impact

• The impact on shareholders is likely to be minimal as the sales were conducted under a pre-arranged plan and the volume of shares sold is small.

Key Dates

Keywords

Northrop Grumman, insider trading, Form 4, stock sale, Rule 10b5-1, director, NOC